Topical timolol 0.5% as the primary treatment of ophthalmic pyogenic granuloma: A prospective, single-arm study

Purpose: To study topical timolol (0.5%) as a first-line treatment in ophthalmic pyogenic granuloma (PG) in terms of safety and efficacy. Methods: This was a prospective, interventional, single-arm study conducted at a tertiary eye care hospital in central India. Only new cases of PG were counseled...

Descrición completa

Detalles Bibliográficos

Principais autores:	Hrishabh Jaiswal, Narendra Patidar, Chintan Shah, Rukmendra Singh, Elesh Jain, Parimal Piyush
Formato:	Artigo
Idioma:	Inglês
Publicado:	Wolters Kluwer Medknow Publications 2021-01-01
Series:	Indian Journal of Ophthalmology
Assuntos:	beta-blocker pyogenic granuloma timolol (0.5%) eye drop
Acceso en liña:	http://www.ijo.in/article.asp?issn=0301-4738;year=2021;volume=69;issue=5;spage=1155;epage=1160;aulast=Jaiswal
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!